Connect with us

Hi, what are you looking for?

Economy

Biden administration greenlights Ukraine’s use of American weapons to strike inside Russia

President Biden has given the green light for Ukraine to use American-made weapons to strike inside Russia, marking a major reversal of policy, Fox News has confirmed. 

A senior U.S. official confirmed that President Biden has signed off on the Ukrainians’ use of U.S. long-range weapons near the city of Kharkiv to protect the second-largest city from ongoing Russian assault. 

The official described the reversal as a ‘limited’ policy shift related to Kharkiv rather than a broad shift in policy that would open up use of U.S. weapons inside Russia. 

‘The president recently directed his team to ensure that Ukraine is able to use U.S.-supplied weapons for counter-fire purposes in the Kharkiv region, so Ukraine can hit back against Russian forces that are attacking them or preparing to attack them,’ the U.S. official said. ‘Our policy with respect to prohibiting the use of ATACMS or long-range strikes inside of Russia has not changed.’

This story was first reported by Politico.

Deputy Pentagon press secretary Sabrina Singh reiterated ‘no change in policy’ multiple times when she was asked about the policy during a briefing Thursday afternoon.

This post appeared first on FOX NEWS

World biggest companies

Learn Trading With Online Courses, Classes, & Lessons

You May Also Like

Investing

2023 was a relatively lackluster year, silver largely traded on volatility between US$22 and US$25 per ounce. The white metal started 2024 with less...

Latest News

Dong’s experience, both as head of the People’s Liberation Army Navy (PLAN) as well as operational assignments in the Chinese military’s Eastern and Southern...

Investing

The US was one of the world’s top silver producers in 2023, recording output of 1,000 metric tons (MT). While that’s far below first-place...

Investing

The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription drug market. But what...

Disclaimer: GreatWallStreetPublisher.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2024 GreatWallStreetPublisher.com